[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2014 2Q14 New Subscribers Reached 15,928 2Q14 Revenue Up 10.3% YOY to RMB141.6 Million 2Q14 Operating Income Up 19.7% YOY to RMB56.3 Million Conference Call to be Held November 15, 2013 at 8:00 a.m. ET HONG KONG, China, November 14, 2013 -- China Cord]
[Biostar Pharmaceuticals, Inc. Regains Compliance With NASDAQ $1.00 Minimum Bid Price Rule BSPM XIANYANG, China, Nov. 13, 2013 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. ( Ronghua Wang, Biostar's Chairman, commenting on the announcement, stated: "We strongly believe that regaining compliance with NASDAQ's continued listing requirements is an important achievement for the Company. Having resolved this issue, we can continue focusing on]
[Contact for Media and Investors: Cassia Curran NetEase,Inc. cassia@corp.netease.com Tel: (+86) 571-8985-2076 Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1) 212-481-2050 NetEase Reports Third Quarter 2013 Unaudited Financial Results (Beijing November13, 2013) NetEase,Inc. (NASDAQ: NTES), one of Chinas leading Internet and online game services providers, today announced its unaudited financial results for the third quarter ended]
[China Ming Yang Wind Power Group Limited Company (the Notice of Annual General Meeting of the Company AGM Notice is hereby given that an Annual General Meeting of the Company (the 1 As an ordinary resolution that the Companys audited consolidated financial statements for the fiscal year ended December 31, 2012 be approved and adopted; 2 As an] [China Ming Yang Wind Power Group Limited Company (the FORM OF PROXY FOR SHAREHOLDERS I/We Please Print Name(s) of Please Print Address(es) being (a) shareholder(s) of the Company with shares respectively hereby appoint of or failing him/her of Chairman AGM or failing him/her the duly appointed chairman of the AGM (the Resolution For Against Abstain 1. As an]
[FORM 10-Q (Mark One) x September 30, 2013 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC Nevada 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 14, 2013 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321093013.htm]
[China Ming Yang Wind Power Group Limited Company (the Notice of Annual General Meeting of the Company AGM Notice is hereby given that an Annual General Meeting of the Company (the 1 As an ordinary resolution that the Companys audited consolidated financial statements for the fiscal year ended December 31, 2012 be approved and adopted; 2 As an] [China Ming Yang Wind Power Group Limited Company (the FORM OF PROXY FOR SHAREHOLDERS I/We Please Print Name(s) of Please Print Address(es) being (a) shareholder(s) of the Company with shares respectively hereby appoint of or failing him/her of Chairman AGM or failing him/her the duly appointed chairman of the AGM (the Resolution For Against Abstain 1. As an]
[FORM 10-Q (Mark One) x September 30, 2013 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC Nevada 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 14, 2013 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321093013.htm]
[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. November 14, 2013 Weibing Lu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. November 14, 2013 Bing Mei Chief Financial Officer]
[FORM 10-Q (Mark One) x September 30, 2013 For the quarterly period ended: Or For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, Maryland 20-8747899 (State or other jurisdiction oforporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 ex32-1.htm 4 EX-32.1] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Qinghua Liu, Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 ex32-2.htm 5 EX-32.2]
[] [Section 302 Certification I, Clarence Chung, certify that: 1) I have reviewed this quarterly report on Form 10-Q of Entertainment Gaming Asia Inc.; 2) Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER Section 302 Certification I, Andy Tsui, certify that: 1) I have reviewed this quarterly report on Form 10-Q of Entertainment Gaming Asia Inc.; 2) Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. Dated: November 14, 2013 Clarence Chung President and Chief Executive Officer Dated: November 14, 2013 Andy Tsui Chief Accounting Officer This certification is made solely for the purposes of 18 U.S.C. Section 1350, subject to the]
